CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Levodropropizine

左羟丙哌嗪 杂质对照品Levodropropizine Impurities

EP45 个杂质条目45 impurity entries

本页汇总 左羟丙哌嗪 的 45 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 45 impurity reference standards of Levodropropizine with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 左羟丙哌嗪(Levodropropizine)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesDevelopment and Validation of a Stability-Indicating LC-Method for the Simultaneous Estimation of Levodropropizine, Chloropheniramine, Methylparaben, Propylparaben, and Levodropropizine Impurities
    Scientia pharmaceutica · 2013 · Kumar PA et al.  ·  PMID 23641334  ·  DOI
  2. 分析方法Analytical MethodsGreen synchronous spectrofluorimetric analysis of remdesivir, the first approved antiviral, with levodropropizine as add-on therapy for covid-19: application in their pharmaceutical dosage form, and spiked human plasma
    BMC chemistry · 2025 · El-Adl SM et al.  ·  PMID 40317008  ·  DOI
  3. 分析方法Analytical MethodsCharacteristics, Properties and Analytical Methods for Determination of Dropropizine and Levodropropizine: A Review
    Critical reviews in analytical chemistry · 2021 · Machado AKMDS et al.  ·  PMID 31814444  ·  DOI
  4. 分析方法Analytical MethodsHPLC determination and steady-state bioavailability study of levodropropizine sustained-release tablets in dogs
    Archives of pharmacal research · 2006 · Yan L et al.  ·  PMID 16833021  ·  DOI
  5. 分析方法Analytical MethodsGreen and inventive fluorescence approach for levodropropizine determination in human plasma
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2024 · Mostafa IM et al.  ·  PMID 38402704  ·  DOI

左羟丙哌嗪 —— 原料药与杂质对照品Levodropropizine — drug substance & impurities

共 46 个条目(含原料药本体)46 items incl. the drug substance
Levodropropizine structure
EP原料药 APIAPI
左羟丙哌嗪Levodropropizine
Levodropropizine
CAS No.99291-25-5
Chemical FormulaC13H20N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 1 (Levodropropizine EP Impurity A) structure
EPA
左羟丙哌嗪杂质1(左羟丙哌嗪EP杂质A)Levodropropizine Impurity 1 (Levodropropizine EP Impurity A)
Levodropropizine Impurity 1 (Levodropropizine EP Impurity A)
CAS No.99291-24-4
Chemical FormulaC13H20N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 41 (N-Nitroso Levodropropizine EP Impurity B) structure
EPB
左羟丙哌嗪杂质41 (N-亚硝基左羟丙哌嗪EP杂质B)Levodropropizine Impurity 41 (N-Nitroso Levodropropizine EP Impurity B)
Levodropropizine Impurity 41 (N-Nitroso Levodropropizine EP Impurity B)
CAS No.14340-33-1
Chemical FormulaC10H13N3O
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 2 (Levodropropizine EP Impurity B) structure
EPB
左羟丙哌嗪杂质2(左羟丙哌嗪EP杂质B)Levodropropizine Impurity 2 (Levodropropizine EP Impurity B)
Levodropropizine Impurity 2 (Levodropropizine EP Impurity B)
CAS No.92-54-6
Chemical FormulaC10H14N2
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 4 (Levodropropizine N-Oxide) structure
4
左羟丙哌嗪杂质4 (左羟丙哌嗪 氮氧化物)Levodropropizine Impurity 4 (Levodropropizine N-Oxide)
Levodropropizine Impurity 4 (Levodropropizine N-Oxide)
CAS No.152237-40-6
Chemical FormulaC13H20N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 5 structure
5
左羟丙哌嗪杂质5Levodropropizine Impurity 5
Levodropropizine Impurity 5
CAS No.2098198-51-5
Chemical FormulaC13H20N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 6 structure
6
左羟丙哌嗪杂质6Levodropropizine Impurity 6
Levodropropizine Impurity 6
CAS No.194799-59-2
Chemical FormulaC11H17N3·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 12 structure
12
左羟丙哌嗪杂质12Levodropropizine Impurity 12
Levodropropizine Impurity 12
CAS No.211116-46-0
Chemical FormulaC13H18N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 13 structure
13
左羟丙哌嗪杂质13Levodropropizine Impurity 13
Levodropropizine Impurity 13
CAS No.1095540-43-4
Chemical FormulaC15H22N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 14 structure
14
左羟丙哌嗪杂质14Levodropropizine Impurity 14
Levodropropizine Impurity 14
CAS No.196811-68-4
Chemical FormulaC16H25N3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 15 structure
15
左羟丙哌嗪杂质15Levodropropizine Impurity 15
Levodropropizine Impurity 15
CAS No.4077-76-3
Chemical FormulaC7H8N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 16 structure
16
左羟丙哌嗪杂质16Levodropropizine Impurity 16
Levodropropizine Impurity 16
CAS No.201810-02-8
Chemical FormulaC13H18N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 17 structure
17
左羟丙哌嗪杂质17Levodropropizine Impurity 17
Levodropropizine Impurity 17
CAS No.1526687-31-9
Chemical FormulaC11H15N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 18 structure
18
左羟丙哌嗪杂质18Levodropropizine Impurity 18
Levodropropizine Impurity 18
CAS No.2639455-19-7
Chemical FormulaC13H21N3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 23 structure
23
左羟丙哌嗪杂质23Levodropropizine Impurity 23
Levodropropizine Impurity 23
CAS No.60456-23-7
Chemical FormulaC3H6O2
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 24 structure
24
左羟丙哌嗪杂质24Levodropropizine Impurity 24
Levodropropizine Impurity 24
CAS No.669050-80-0
Chemical FormulaC11H22N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 25 structure
25
左羟丙哌嗪杂质25Levodropropizine Impurity 25
Levodropropizine Impurity 25
CAS No.54866-86-3
Chemical FormulaC6H6N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 26 structure
26
左羟丙哌嗪杂质26Levodropropizine Impurity 26
Levodropropizine Impurity 26
CAS No.4440-87-3
Chemical FormulaC4H8O3
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 29 structure
29
左羟丙哌嗪杂质29Levodropropizine Impurity 29
Levodropropizine Impurity 29
CAS No.1629584-89-9
Chemical FormulaC14H20N4O
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 31 structure
31
左羟丙哌嗪杂质31Levodropropizine Impurity 31
Levodropropizine Impurity 31
CAS No.838886-46-7
Chemical FormulaC11H13ClN4O3
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 32 structure
32
左羟丙哌嗪杂质32Levodropropizine Impurity 32
Levodropropizine Impurity 32
CAS No.54267-47-9
Chemical FormulaC6H13ClN2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 32 Monomer structure
32
左羟丙哌嗪杂质32 单体Levodropropizine Impurity 32 Monomer
Levodropropizine Impurity 32 Monomer
CAS No.61308-25-6
Chemical FormulaC6H13ClN2
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 33 structure
33
左羟丙哌嗪杂质33Levodropropizine Impurity 33
Levodropropizine Impurity 33
CAS No.151447-85-7
Chemical FormulaC11H15ClN2
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 34 structure
34
左羟丙哌嗪杂质34Levodropropizine Impurity 34
Levodropropizine Impurity 34
CAS No.835916-78-4
Chemical FormulaC14H20N2
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 35 structure
35
左羟丙哌嗪杂质35Levodropropizine Impurity 35
Levodropropizine Impurity 35
CAS No.25057-77-6
Chemical FormulaC6H14N2
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 36 structure
36
左羟丙哌嗪杂质36Levodropropizine Impurity 36
Levodropropizine Impurity 36
CAS No.89989-06-0
Chemical FormulaC12H18N2O
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 37 structure
37
左羟丙哌嗪杂质37Levodropropizine Impurity 37
Levodropropizine Impurity 37
CAS No.5430-78-4
Chemical FormulaC8H14N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 38 structure
38
左羟丙哌嗪杂质38Levodropropizine Impurity 38
Levodropropizine Impurity 38
CAS No.70987-78-9
Chemical FormulaC10H12O4S
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 39 structure
39
左羟丙哌嗪杂质39Levodropropizine Impurity 39
Levodropropizine Impurity 39
CAS No.1135243-19-4
Chemical FormulaC18H20N6O3S2
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 40 structure
40
左羟丙哌嗪杂质40Levodropropizine Impurity 40
Levodropropizine Impurity 40
CAS No.57044-25-4
Chemical FormulaC3H6O2
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 44 structure
44
左羟丙哌嗪杂质44Levodropropizine Impurity 44
Levodropropizine Impurity 44
CAS No.57184-25-5
Chemical FormulaC8H16N2
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 49 structure
49
左羟丙哌嗪杂质49Levodropropizine Impurity 49
Levodropropizine Impurity 49
CAS No.1048664-14-7
Chemical FormulaC8H15BrN2O·HBr
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 49 Monomer structure
49
左羟丙哌嗪杂质49 单体Levodropropizine Impurity 49 Monomer
Levodropropizine Impurity 49 Monomer
CAS No.696623-56-0
Chemical FormulaC8H15BrN2O
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 50 structure
50
左羟丙哌嗪杂质50Levodropropizine Impurity 50
Levodropropizine Impurity 50
CAS No.192130-34-0
Chemical FormulaC11H23N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 51 structure
51
左羟丙哌嗪杂质51Levodropropizine Impurity 51
Levodropropizine Impurity 51
CAS No.98961-97-8
Chemical FormulaC6H15N3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 52 structure
52
左羟丙哌嗪杂质52Levodropropizine Impurity 52
Levodropropizine Impurity 52
CAS No.3022-15-9
Chemical FormulaC5H10N2O2·2HCl
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 53 structure
53
左羟丙哌嗪杂质53Levodropropizine Impurity 53
Levodropropizine Impurity 53
CAS No.49715-78-8
Chemical FormulaC4H2N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 54 structure
54
左羟丙哌嗪杂质54Levodropropizine Impurity 54
Levodropropizine Impurity 54
CAS No.17692-31-8
Chemical FormulaC13H20N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 56 structure
56
左羟丙哌嗪杂质56Levodropropizine Impurity 56
Levodropropizine Impurity 56
CAS No.7709-78-6
Chemical FormulaC8H14N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 57 structure
57
左羟丙哌嗪杂质57Levodropropizine Impurity 57
Levodropropizine Impurity 57
CAS No.2425-79-8
Chemical FormulaC10H18O4
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 60 structure
60
左羟丙哌嗪杂质60Levodropropizine Impurity 60
Levodropropizine Impurity 60
CAS No.147081-80-9
Chemical FormulaC9H19N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 61 structure
61
左羟丙哌嗪杂质61Levodropropizine Impurity 61
Levodropropizine Impurity 61
CAS No.119891-85-9
Chemical FormulaC14H26N2
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 62 structure
62
左羟丙哌嗪杂质62Levodropropizine Impurity 62
Levodropropizine Impurity 62
CAS No.120737-78-2
Chemical FormulaC10H20N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 63 structure
63
左羟丙哌嗪杂质63Levodropropizine Impurity 63
Levodropropizine Impurity 63
CAS No.5271-27-2
Chemical FormulaC11H16N2
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 64 structure
64
左羟丙哌嗪杂质64Levodropropizine Impurity 64
Levodropropizine Impurity 64
CAS No.1359658-45-9
Chemical FormulaC7H16N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Levodropropizine Impurity 66 structure
66
左羟丙哌嗪杂质66Levodropropizine Impurity 66
Levodropropizine Impurity 66
CAS No.6284-84-0
Chemical FormulaC6H14N2
Purity>95%询价On request
10mg25mg50mg100mg
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

左羟丙哌嗪 —— 研究文献与合成路线Levodropropizine — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 左羟丙哌嗪 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Levodropropizine. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Development and Validation of a Stability-Indicating LC-Method for the Simultaneous Estimation of Levodropropizine, Chloropheniramine, Methylparaben, Propylparaben, and Levodropropizine Impurities
    Kumar PA, Raju TV, Thirupathi D, et al. · Scientia pharmaceutica · 2013 · 被引 10cited 10

合成与制备工艺专利Synthesis & process patents

  1. Technique for synthesizing levodropropizine
    ZHIHONG ZHU, ZHENJUN BU · 公开号 CN101239952CN101239952 · 2008
  2. Levodropropizine lozenge and preparation method thereof
    QIUSHENG ZHANG, XIANG GAO, ZHI LIU · 公开号 CN101317824CN101317824 · 2008
  3. PROCESS FOR PREPARING LEVODROPROPIZINE UNDER MILD TEMPERATURE USING INEXPENSIVE INTERMEDIATE TO IMPROVE YIELD AND SIMPLIFY PROCESS
    KIM DAE SIC, LEE JAE HYOUNG · 公开号 KR20050021077KR20050021077 · 2005

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

左羟丙哌嗪 杂质谱研究要点Levodropropizine — impurity profiling notes

下面这些是拿到 左羟丙哌嗪 的 46 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 46 impurity entries for Levodropropizine, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances